Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Generic Drug Economic Experts

Council Members in this Study Group: 740

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Survey or engage members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Louis Rocco

System Director of Purchasing
HALLMARK HEALTH SYSTEM, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Louis Rocco is the System Director of Purchasing at Hallmark Health System, Inc., Massachusetts. He has over 23 years of experience in purchasing with negotiation, analytical, reporting and communication skills with inventory, distribution, purchasing, mailroom and accounts payable background. Mr.Rocco...

Stephen Bent, Partner, FOLEY & LARDNER LLPStephen Bent

Partner
FOLEY & LARDNER LLP
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Stephen A. Bent is Partner and former co-leader of the Life Sciences Industry Team at Foley & Lardner in Washington, DC. He is also a member of the Biotechnology & Pharmaceutical Practice Group and the Health Care and Nanotechnology Industry Teams. Mr. Bent specializes on the legal issues associated...

Michael McNeely

Principal
Law Offices of Michael D. McNeely
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Michael McNeely is in private practice in Washington, DC, where he provides antitrust counseling and representation. Mr. McNeely consults on the antitrust and antitrust agency aspects of mergers, generic drug approvals, telecommunications, patents, standard setting, and other topics. He also represents...

Adam Fein, PhD, Founder & President, PEMBROKE CONSULTING INCAdam Fein, PhD

Founder & President
PEMBROKE CONSULTING INC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Adam Fein, PhD, is the Founder and President of Pembroke Consulting, Inc., a Philadelphia-based management advisory and business research firm. Dr. Fein is one of the country’s foremost experts on pharmacy economics and the pharmaceutical supply chain. He provides strategic advisory services to a diverse...

2 recent news post(s)
Eric Gruff, PhD MBA, Principal, E4 ConsultingEric Gruff, PhD MBA

Principal
E4 Consulting
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Eric Gruff, PhD, MBA, BS, is Founder of E4 Consulting, which specializes in pharmaceutical development, regulatory affairs, and project and portfolio management. Dr. Gruff has over 17 years of experience in the pharmaceutical and biotech sector, including leadership roles at Pfizer, Agouron Pharmaceuticals,...

Leo Pavliv, RPh, MBA

VP Operations
CUMBERLAND PHARMACEUTICALS, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Leo Pavliv, RPh, MBA, is Vice President Operations at Cumberland Pharmaceuticals in Tennessee. His job responsibilities include directing overall drug development activities for numerous products, regulatory affairs, product development, clinical and non-clinical development, manufacturing, and quality...

Dea Belazi, PharmD, MPH, PAHM, Pharmacy Consultant, Dea Belazi, PharmD, MPH, PAHMDea Belazi, PharmD, MPH, PAHM

Pharmacy Consultant
Dea Belazi, PharmD, MPH, PAHM
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Dea Belazi, PharmD, MPH, PAHM, is currently a Consultant working with health plans and pharmaceutical companies. Dr. Belazi is also a Consulting Practice Leader for Wolters Kluwer Health- Managed Care Group. Previously, he was the Senior Director of Pharmacy Services for Independence Blue Cross, alarge...

2 recent event(s)
Robert Dondes

Independent Consultant
Robert Dondes, Consultant
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Robert Dondes is an Independent Consultant based in the mid-Atlantic United States, with headquarters in Maryland. His private practice focuses on managed care, health insurance, strategic analysis, and operational improvement. Mr. Dondes is affiliated with the consulting division of the Pennsylvania...

2 recent event(s)

View all Leading Experts in this Study Group

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Generics seek brands, Big pharma seek generics!

July 1, 2009

GLG Expert Contributor

Lupin Expands Branded Play | www.sunherald.com

Generic companies have the creative R&D to develop value-added products and compete head-to-head with branded companies Branded companies see generics as an easy way to add products for their sales teams

Prescription Brand Bullys vs Generic Go-Getters

June 25, 2009

GLG Expert Contributor

GSK announces a strategic alliance with Dr. Reddy's Laboratories Ltd | www.pharmanews.eu

With all of the hullabaloo being put forth by Big Pharma over the last several years, it is interesting to see the upcoming alliance between GSK and Dr Reddy. Today, the major pharmaceutical companies have manufacturing plants in over 30 countries around the world. U.S. customers still believe that...

Evaluation of Influenza Vaccines

May 20, 2009

GLG Expert Contributor

Novartis receives swine flu virus | newsinfo.inquirer.net

Scientists, medical professionals and the public know that by the time new flu vaccines are produced for use that the specific outbreak is far into the past and the vaccine is no longer in need and is destroyed. Novartis and other vaccine production companies need to dedicate more...

Nycomed’s Daxas takes an important step forward

May 12, 2009

John Ansell, MBA, Director, John Ansell Consultancy

Nycomed files European marketing authorisation application for Daxas® in COPD | www.pipelinereview.com

With the recent setbacks to Almirall’s clidinium bromide – it is not now scheduled to re-enter the regulatory fray until late 2011/early 2012 -  the way has opened up for the PDE4 inhibitor Daxas (roflumilast) to be the next big thing in COPD. If it can only overcome the final, regulatory hurdles,...

Sequenom's delay

May 4, 2009

Alan Patterson, MD, Obstetrician and Gynecologist, ALAN B PATTERSON MD, PA

UPDATE 2-Sequenom delays Down Syndrome test; shares plunge | uk.reuters.com

This delay is not good for the company, especially since there are already tests in place that are effective to screen for Down's syndrome.  These tests now are the standard of care, so the longer it takes for Sequenon to launch it's test the worse, for the company.

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Pharmaceuticals Manufacturer
  • Consultancy, Pharma-Focused
  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Pharmacy or Drug Store, Chain
  • Consultancy, Healthcare-Focused
  • Pharmacy or Drug Store, Independent/Local
  • Individual/Small Consultancy

Members in this Study Group often have these job titles:

  • Director
  • President
  • Pharmacist - RPh/PharmD
  • Owner
  • Physician - Attending Physician
  • Chief Executive Officer
  • Principal
  • Consultant
  • Manager
  • Operations Executive

Related Study Groups

Study Group Name No. Members
Pharmacists (US) 2100
Experts on Generic Pharmaceuticals: Pharmacists 106
Economic Experts on Managed Care 675
Formulary Design Experts 241
Managed Care Experts 660
Medicare Experts 491
Managed Care Pricing Trends Experts 277

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Generic Drug Economic Experts Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

GLG Webcasts

Leading Experts in Generic Drug Economic Experts have not participated in any GLG webcasts.

View All GLG Webcasts in Healthcare

Popular Topics in Healthcare